BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Johnson & Johnson Drug Shines in Trial Against Standard Lung-clot Drugs

  March 26, 2012

   · 

  1 min read
• Job Trends

  MagForce Nanotechnologies Cuts Jobs, Restructures

  March 26, 2012

   · 

  4 min read
• Lone Star Bio

  BiO2 Medical, Inc. Raises $13.7 Million

  March 26, 2012

   · 

  1 min read
• BioMidwest

  Edwards Lifesciences Sapien Safely Replaces Aortic Valves at Two Years

  March 26, 2012

   · 

  5 min read
• Biotech Bay

  Agilent Technologies, Inc. (Santa Clara, California) Target-Enrichment for Next-Generation Sequencers Now Runs Four Times Faster

  March 26, 2012

   · 

  2 min read
• FDA

  VectraCor Inc. Receives FDA Approval for Real-Time Detection of ECG Changes Suggestive of AMI

  March 26, 2012

   · 

  2 min read
• Business

  Celtic Therapeutics Pledges $50 Million to Establish ADC Therapeutics, New Company Will Develop Antibody-Drug Conjugates

  March 26, 2012

   · 

  6 min read
• Drug Development

  Merck & Co., Inc.'s Vorapaxar in Limbo After Mixed Results

  March 26, 2012

   · 

  8 min read
• Deals

  “Corrupt” Lab Practices Pushes CRO Firm Cetero Research Into Bankruptcy

  March 26, 2012

   · 

  1 min read
• Drug Development

  Optimer Pharmaceuticals, Inc.: Lancet Infectious Diseases Reveals Phase 3 Trial Results Of DIFICID

  March 26, 2012

   · 

  8 min read